US2004043426A1PendingUtilityA1
Methods for ligand discovery
Priority: Jun 26, 1998Filed: Jun 18, 2003Published: Mar 4, 2004
Est. expiryJun 26, 2018(expired)· nominal 20-yr term from priority
C40B 30/04C07D 405/12G01N 33/6845C07D 333/70C07D 207/46C40B 40/04C07D 333/38C40B 20/08C07D 401/04C12Q 1/70C12Q 1/00G01N 33/53C07C 323/25
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides novel methods for ligand discovery. The inventive methods rely on a process termed “tethering” where potential ligands are covalently bonded or “tethered” to a target and subsequently identified.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method comprising
a) contacting a target that comprises a chemically reactive group at or near a site of interest with a compound that is capable of forming a covalent bond with the chemically reactive group; b) forming a covalent bond between the target and the compound thereby forming a target-compound conjugate; and, c) identifying the target-compound conjugate by subjecting the target-compound conjugate to mass spectrometry.
2 . A mass spectrometer comprising a target-compound conjugate.
3 . A target-compound conjugate selected from the group consisting of
wherein
is the target, R and R′ are each independently unsubstituted C 1 -C 20 aliphatic, substituted C 1 -C 20 aliphatic, unsubstituted aryl, or substituted aryl;
m is 0, 1, or 2; and
n is 1 or 2.
4 . The target-compound conjugate of claim 3 wherein the target is a polypeptide.
5 . The target-compound conjugate of claim 4 wherein the covalent bond between the —S—S— group and the
target is reversible.
6 . The target-compound conjugate of claim 4 wherein the covalent bond between the —S—S— group and the
target is irreversible.
7 . The target-compound conjugate of claim 4 wherein the target is selected from the group consisting of enzymes, receptors, transcription factors, ligands for receptors, growth factors, cytokines, immunoglobulins, nuclear proteins, signal transduction components, and allosteric enzyme regulators.
8 . A method comprising:
a) contacting a target protein that is capable of forming a disulfide bond with a ligand candidate that is also capable of forming a disulfide bond; b) forming a disulfide bond between the target protein and the ligand candidate thereby forming a target-ligand conjugate; and c) identifying the ligand present in the target protein-ligand conjugate.
9 . The method as in claim 8 wherein the contacting step occurs in the presence of a reducing agent.
10 . The method as in claim 8 wherein the identification occurs using mass spectrometry.
11 . The method as in claim 8 wherein the identification occurs using a labeled probe.
12 . The method as in claim 8 wherein the identification occurs using a functional assay.
13 . The method as in claim 8 wherein the identification occurs using chromatography.
14 . The method as in claim 8 wherein the identification occurs using surface plasmon resonance.
15 . The method as in claim 8 wherein the ligand candidate is selected from the group comprising
wherein R and R′ are each independently unsubstituted C 1 -C 20 aliphatic, substituted C 1 -C 20 aliphatic, unsubstituted aryl, or substituted aryl;
m is 0, 1, or 2; and,
n is 1 or 2.
16 . The method of claim 8 wherein the target protein comprises an —SH group from a cysteine that is part of the native amino acid sequence of said protein.
17 . The method of claim 8 wherein the target protein has comprises an engineered —SH group from a cysteine introduced into the amino acid sequence of said protein.
18 . A library of compounds wherein each member comprises a moiety —SSR 1 where R 1 is unsubstituted C 1 -C 10 aliphatic, substituted C 1 -C 10 aliphatic, unsubstituted aryl, and wherein each member has a different mass.
19 . The library of claim 18 having at least 5 members.
20 . The library of claim 18 having at least 100 members.
21 . The library of claim 18 wherein each member library has a mass that differs from another member of the library by at least 5 atomic mass units.
22 . The library of claim 18 wherein each member has a mass that differs from another member of the library by at least 10 atomic mass units.
23 . A method comprising:
a) identifying a first compound of the formula R D SSR 1 that binds to a target protein; b) identifying a second compound of the formula R E SSR 1 that binds to a target protein; and c) forming a conjugate compound comprising R D and R E wherein R D and R E are each independently C 1 -C 20 unsubstituted aliphatic, C 1 -C 20 substituted aliphatic, unsubstituted aryl, and substituted aryl; and R 1 is unsubstituted C 1 -C 10 aliphatic, substituted C 1 -C 10 aliphatic, unsubstituted aryl.
24 . The method of claim 23 wherein the identification of the second compound that binds to the target occurs in the presence of the first compound.
25 . The method of claim 23 wherein R D SSR 1 and R E SSR 1 are each independently selected from the group consisting of
wherein R and R′ are each independently unsubstituted C 1 -C 20 aliphatic, substituted C 1 -C 20 aliphatic, unsubstituted aryl, or substituted aryl;
m is 0, 1, or 2; and,
n is 1 or 2.
26 . A method comprising
a) providing a target having an anchoring group that is capable of forming a covalent bond or coordinating a metal at or near a site of interest; b) contacting the target with an extender thereby forming a target-extender complex wherein the extender comprises a first functionality that forms either a covalent bond or coordinates a metal and a second functionality that is capable of forming a covalent bond; c) contacting the target-extender complex with a candidate ligand that comprises a group that is capable of forming a covalent bond with the second functionality; d) forming a covalent bond between the target-extender complex and the candidate ligand; and, e) identifying the candidate ligand present in the target-extender-ligand conjugate.
27 . The method of claim 26 wherein the anchoring group is selected from a group consisting of a reactive electrophile, a reactive nucleophile, and a metal coordination site.
28 . A method comprising:
a) providing a target having a reactive nucleophile at or near a site of interest; b) contacting the target with an extender thereby forming a target-extender complex wherein the extender comprises a first functionality that reacts with the nucleophile in the target to form a covalent bond and a second functionality that is capable of forming a disulfide bond; c) contacting the target-extender complex with a ligand candidate that is capable of forming a disulfide bond; d) forming a disulfide bond between the target-extender complex and the ligand candidate thereby forming a target-extender-ligand conjugate; and, e) identifying the ligand candidate present in the target-extender-ligand conjugate.
29 . The method as in claim 28 wherein the reactive nucleophile on the target is a thiol or a masked thiol.
30 . The method of claim 28 wherein the extender is of the formula:
where R is unsubstituted C 1 -C 20 aliphatic, substituted C 1 -C 20 aliphatic, unsubstituted aryl, and substituted aryl; R′ is H, —SR 1 wherein R 1 is unsubstituted C 1 -C 10 aliphatic, substituted C 1 -C 10 aliphatic, unsubstituted aryl, and substituted aryl; X is a leaving group, and the boxes in each formula represent a binding determinant.
31 . The method of claim 28 wherein the extender is of the formula:
where R′ is H, —SR 1 wherein R 1 is unsubstituted C 1 -C 10 aliphatic, substituted C 1 -C 10 aliphatic, unsubstituted aryl, and substituted aryl, and the boxes represent a binding determinant.Join the waitlist — get patent alerts
Track US2004043426A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.